BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16787496)

  • 1. Incidence of invasive fungal infection in adult haematological malignancy: a prospective validation of a risk stratification scheme.
    Moreno JM; Alhambra A; Cuétara MS; Ortiz MC; Pontón J; del Palacio-Pérez-Medel A; del Palacio A
    Br J Haematol; 2006 Aug; 134(3):343-5. PubMed ID: 16787496
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
    Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
    J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Feasibility of galactomannan assay in bronchoalveolar lavage fluid in diagnosis of hematologic malignancy patients with invasive fungal infections].
    Leng Y; Chen WM; Liu JW
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):551-2. PubMed ID: 22338180
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations in the approach to invasive fungal infection in patients with haematological malignancies.
    Bow EJ
    Br J Haematol; 2008 Jan; 140(2):133-52. PubMed ID: 18173752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
    Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
    Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies.
    Riwes MM; Wingard JR
    Expert Rev Hematol; 2012 Dec; 5(6):661-9. PubMed ID: 23216596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of infectious complications in hemato-oncological patients.
    Ram R; Gafter-Gvili A; Raanani P; Yeshurun M; Shpilberg O; Dreyer J; Peck A; Leibovici L; Paul M
    Isr Med Assoc J; 2009 Mar; 11(3):133-7. PubMed ID: 19544700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies.
    Wang JT; Yao M; Tang JL; Chang SC; Hung CC
    J Clin Oncol; 2001 Oct; 19(19):4000-1. PubMed ID: 11579127
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
    Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
    Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive fungal infection in Ramathibodi Hospital: a ten-year autopsy review.
    Larbcharoensub N; Srisuma S; Ngernprasertsri T; Aroonroch R; Chongtrakool P; Santanirand P; Chirachariyavej T; Sirikulchayanonta V
    J Med Assoc Thai; 2007 Dec; 90(12):2630-7. PubMed ID: 18386713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive mycoses in children receiving hemopoietic SCT.
    Castagnola E; Faraci M; Moroni C; Bandettini R; Granata C; Caruso S; Bagnasco F; Caviglia I; Malgorzata M; Furfaro E; Natalizia AR; de Fazio V; Morreale G; Lanino E; Haupt R; Dini G; Viscoli C
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S107-11. PubMed ID: 18545231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and serological diagnosis of invasive aspergillosis: new answers to old questions?
    Hummel M; Buchheidt D
    Mycoses; 2007; 50 Suppl 1():18-23. PubMed ID: 17394606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.
    Suankratay C; Kanitcharaskul P; Arunyingmongkol K
    J Med Assoc Thai; 2006 Nov; 89(11):1851-8. PubMed ID: 17205865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deep mycosis in patients with hematological diseases].
    Yoshida M
    Rinsho Ketsueki; 2008 Aug; 49(8):567-75. PubMed ID: 18800604
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating antigens in systemic fungal diseases.
    de Repentigny L
    Immunol Ser; 1989; 47():471-84. PubMed ID: 2490087
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
    Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
    Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases.
    Cesaro S; Stenghele C; Calore E; Franchin E; Cerbaro I; Cusinato R; Tridello G; Manganelli R; Carli M; Palù G
    Mycoses; 2008 Nov; 51(6):497-504. PubMed ID: 18331444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phaeohyphomycosis in a tertiary care cancer center.
    Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
    Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.